Cloverleafbio
Founded 2023 · 4 employees on LinkedIn · 1 known investors
Cloverleaf Bio is developing engineered tRNA therapeutics for oncology, designed to inhibit multiple enzymes required for cancer growth from a single molecule. The company focuses on cancer treatment within the biotech and therapeutics space.
Founders & leadership
Cloverleafbio was founded in 2023 by Austin Draycott, Wendy Gilbert, and Cole Lewis.
Investors · 1
Frequently asked questions
- What does Cloverleafbio do?
- Cloverleaf Bio is developing engineered tRNA therapeutics for oncology, designed to inhibit multiple enzymes required for cancer growth from a single molecule. The company focuses on cancer treatment within the biotech and therapeutics space.
- Who founded Cloverleafbio?
- Cloverleafbio was founded by Austin Draycott, Wendy Gilbert, Cole Lewis in 2023.
- Who are Cloverleafbio's investors?
- Cloverleafbio's investors include Draper Associates.